Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-11-30

Clinical Trial Update: Efficacy of Artesunate-amodiaquine (AS-AQ) in Children With Malaria and Severe Acute Malnutrition, Madaoua, Niger 2010 [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating artesunate-amodiaquine in children with falciparum malaria and severe acute malnutrition in Niger has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate-amodiaquine (artesunate-amodiaquine)

Snippet

Sponsor: Epicentre | Conditions: Malaria, Falciparum, Malnutrition | Phase 4 | Status: WITHDRAWN